Physiogenex and Cardiomedex to present a new diabetic NASH HFpEF
Por um escritor misterioso
Descrição
Physiogenex and Cardiomedex to present a new diabetic NASH HFpEF hamster model at the Keystone conference
Heart failure in type 2 diabetes: current perspectives on
Physiogenex on LinkedIn: Physiogenex is at ILC-EASL 2022 in London
Elafibranor improves diet-induced nonalcoholic steatohepatitis
Heart Failure with Preserved Ejection Fraction and Obstructive
Physiogenex to attend The Keystone Symposia Immunometabolism
Cardiometabolic HFpEF: NASH of the Heart
Elafibranor improves diet-induced nonalcoholic steatohepatitis
Therapeutic approaches in heart failure with preserved ejection
Rana Assaly على LinkedIn: #hfpef #diastolic_dysfunction
Natália Breyner - Scientist/Project Manager/R&D at Physiogenex
Obesity-Related Heart Failure With a Preserved Ejection Fraction
de
por adulto (o preço varia de acordo com o tamanho do grupo)
